Nationwide cohort study: Association between medical androgen deprivation therapy and long-term cardiovascular disease and all-cause mortality in nonmetastatic prostate cancer.
3 Jun, 2022 | 11:10h | UTCCommentary: ADT for Prostate Cancer: What’s the Risk on the Heart? – Medscape (free registration required)